CN110755571B - Pu Shu tea and application thereof - Google Patents

Pu Shu tea and application thereof Download PDF

Info

Publication number
CN110755571B
CN110755571B CN201911191416.5A CN201911191416A CN110755571B CN 110755571 B CN110755571 B CN 110755571B CN 201911191416 A CN201911191416 A CN 201911191416A CN 110755571 B CN110755571 B CN 110755571B
Authority
CN
China
Prior art keywords
parts
breast
raw material
dandelion
shu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201911191416.5A
Other languages
Chinese (zh)
Other versions
CN110755571A (en
Inventor
蔡元元
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201911191416.5A priority Critical patent/CN110755571B/en
Publication of CN110755571A publication Critical patent/CN110755571A/en
Application granted granted Critical
Publication of CN110755571B publication Critical patent/CN110755571B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288Taraxacum (dandelion)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287Chrysanthemum, e.g. daisy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/535Perilla (beefsteak plant)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738Rosa (rose)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9064Amomum, e.g. round cardamom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Abstract

The invention relates to a Pu Shu tea which is prepared from the following raw material medicines in parts by weight: 10-30 parts of dandelion, 10-30 parts of rose, 10-30 parts of chicory, 10-30 parts of chrysanthemum, 3-15 parts of perilla leaves, 3-15 parts of caulis perillae, 3-6 parts of fructus amomi, 10-30 parts of lettuce seeds, 10-30 parts of fried white hyacinth beans and 5-15 parts of liquorice. The invention also provides application of the Pu Shu tea in preparation of a medicine for treating acute mastitis. The acute mastitis is: mammary swelling and pain, milk accumulation, thick milk, early mastitis and early pus formation in lactation. The invention has the advantages that: the compatibility principle of 'monarch, minister, assistant and guide' is met among the raw material medicines. The composition has reasonable and delicate compatibility, thus achieving good clinical curative effect.

Description

Pu Shu tea and application thereof
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a Pu Shu tea and application thereof.
Background
Mastitis is a common acute suppurative disease of postpartum women in lactation, is common to primiparous women, and is better to occur 1-4 weeks postpartum, so the mastitis is called postpartum acute mastitis; of course, other periods may occur. The traditional Chinese medicine considers that the disease is mostly caused by overeating the thick taste and heat accumulation in the stomach channel; or worry, anger, stagnated fire in liver meridian; or rupture of the skin of the nipple, invasion of exogenous pathogenic fire-toxin into the breast, etc., which results in different veins of the breast, unsmooth milk discharge, and mutual coagulation of stagnated heat-toxin and accumulated milk, thereby forming swelling and carbuncle. Acute mastitis is clinically manifested as lump, swelling and pain in breast, accompanied by fever, pus out and thick after ulceration.
In the prior art, both western medicines and traditional Chinese medicines have certain defects, and the treatment effect is not obvious.
Such as: the Chinese patent application: CN101095825A, which is a Chinese patent medicine containing seven crude drugs, namely snakegourd peel, dandelion, salvia miltiorrhiza, red paeony root, paniculate bolbostemma rhizome, radix bupleuri and rhizoma corydalis; the number of raw material medicines is large, and the curative effect is not exact. No report is found about the tea substitute for effectively treating acute mastitis.
Disclosure of Invention
The first purpose of the invention is to provide the Pu Shu tea aiming at the defects of the prior art.
The second purpose of the invention is to provide the application of the Pu Shu tea aiming at the defects of the prior art.
In order to realize the first purpose, the invention adopts the technical scheme that: the Pu Shu tea is prepared from the following raw material medicines in parts by weight: 10-30 parts of dandelion, 10-30 parts of rose, 10-30 parts of chicory, 10-30 parts of chrysanthemum, 3-15 parts of perilla leaves, 3-15 parts of caulis perillae, 3-6 parts of fructus amomi, 10-30 parts of lettuce seeds, 10-30 parts of fried white hyacinth beans and 5-15 parts of liquorice.
As a preferred embodiment of the invention, the Pu Shu tea is prepared from the following raw material medicines in parts by weight: 15-25 parts of dandelion, 15-25 parts of rose, 15-25 parts of chicory, 15-25 parts of chrysanthemum, 5-12 parts of perilla leaves, 5-12 parts of caulis perllae, 3-6 parts of fructus amomi, 15-25 parts of lettuce seeds, 15-25 parts of fried white hyacinth beans and 7-12 parts of liquorice.
As a preferred embodiment of the invention, the Pu Shu tea is prepared from the following raw material medicines in parts by weight: 20 parts of dandelion, 20 parts of rose, 20 parts of chicory, 20 parts of chrysanthemum, 9 parts of perilla leaves, 9 parts of perilla stems, 5 parts of fructus amomi, 20 parts of lettuce seeds, 20 parts of fried white hyacinth beans and 10 parts of liquorice.
In order to achieve the second purpose, the invention adopts the technical scheme that: application of Pushu tea in preparing medicine for treating acute mastitis is provided.
As a preferred embodiment of the invention, said acute mastitis is: mammary swelling and pain, milk accumulation, thick milk, early mastitis and early pus formation in lactation.
Square solution: dandelion which is the first essential medicine for acute mastitis is taken as a monarch drug to clear away heat and toxic materials, eliminate carbuncle and furuncle and clear away damp-heat; chrysanthemum with the functions of clearing away heat and toxic materials and chicory with the functions of clearing away heat and toxic materials, relieving swelling and invigorating stomach are taken as ministerial drugs to strengthen the functions of dandelion in clearing away heat and toxic materials, eliminating carbuncle and dissipating furuncle; the perilla leaves, the perilla stems, the fructus amomi and the white hyacinth beans are matched to warm the middle-jiao and strengthen the spleen, protect the spleen and stomach and prevent cold and cool from hurting the middle-jiao; can also prevent cold and cool, congealing qi and blood, and avoiding the trouble of converting mastitis into outcome; the lettuce seeds have the functions of promoting lactation, promoting blood circulation and removing blood stasis. The rose flower has the functions of regulating qi and promoting blood circulation. Are all adjuvant drugs. Licorice root, radix Glycyrrhizae regulates the middle warmer, and coordinates the effects of the other drugs in the recipe, acting as a guiding drug.
The invention has the advantages that:
1. the raw materials in the formula accord with the compatibility principle of 'monarch, minister, assistant and guide'. The composition has reasonable and delicate compatibility, thus achieving good clinical curative effect. The invention is a clinical service proved recipe of 12 years old by the inventor, uses more than 4 thousands of cases at present, has no ineffectiveness, is homologous in medicine and food, and is safe and reliable.
2. The optimal proportion among the raw material medicines is obtained through experimental screening, and the method has the advantage of remarkable effect.
3. The raw material medicines have wide sources, the preparation method is simple and convenient, the medicine is convenient for patients to take, the acceptability of the patients is improved, the convenience is brought to the patients, the curative effect is good, the medicine can be well applied to clinic, and the medicine has good application prospect.
Detailed Description
The invention will be further illustrated with reference to specific embodiments. It should be understood that these examples are for illustrative purposes only and are not intended to limit the scope of the present invention. Furthermore, it should be understood that various changes and modifications can be made by those skilled in the art after reading the disclosure of the present invention, and equivalents fall within the scope of the appended claims.
Example 1 Pu Shu tea composition (I)
The raw material medicaments are taken according to the following weight portion:
20 parts of dandelion, 20 parts of rose, 20 parts of chicory, 20 parts of chrysanthemum, 9 parts of perilla leaves, 9 parts of perilla stems, 5 parts of fructus amomi, 20 parts of lettuce seeds, 20 parts of fried white hyacinth beans and 10 parts of liquorice.
Example 2 Pu Shu tea composition (II)
The raw material medicaments are taken according to the following weight portion:
15 parts of dandelion, 15 parts of rose, 25 parts of chicory, 25 parts of chrysanthemum, 3 parts of perilla leaves, 3 parts of perilla stems, 6 parts of fructus amomi, 30 parts of lettuce seeds, 20 parts of fried white hyacinth beans and 10 parts of liquorice.
Example 3 Pu Shu tea composition (III)
The raw material medicaments are taken according to the following weight portion:
25 parts of dandelion, 25 parts of rose, 10 parts of chicory, 10 parts of chrysanthemum, 15 parts of perilla leaves, 15 parts of perilla stems, 5 parts of fructus amomi, 20 parts of lettuce seeds, 15 parts of fried white hyacinth beans and 7 parts of liquorice.
Example 4 Pu Shu tea composition (IV)
The raw material medicaments are taken according to the following weight portion:
10 parts of dandelion, 10 parts of rose, 30 parts of chicory, 30 parts of chrysanthemum, 9 parts of perilla leaves, 9 parts of perilla stems, 3 parts of fructus amomi, 15 parts of lettuce seeds, 25 parts of fried white hyacinth beans and 12 parts of liquorice.
Example 5 Pu Shu tea composition (V)
The raw material medicaments are taken according to the following weight portion:
30 parts of dandelion, 30 parts of rose, 20 parts of chicory, 20 parts of chrysanthemum, 5 parts of perilla leaves, 5 parts of perilla stems, 6 parts of fructus amomi, 25 parts of lettuce seeds, 10 parts of fried white hyacinth beans and 5 parts of liquorice.
Example 6 Pu Shu tea composition (six)
The raw material medicaments are taken according to the following weight portion:
20 parts of dandelion, 20 parts of rose, 20 parts of chicory, 15 parts of chrysanthemum, 5 parts of perilla leaves, 5 parts of perilla stems, 6 parts of fructus amomi, 25 parts of lettuce seeds, 25 parts of fried white hyacinth beans and 5 parts of liquorice.
Example 7 Pu Shu tea composition (seven)
The raw material medicaments are taken according to the following weight portion:
30 parts of dandelion, 10 parts of rose, 25 parts of chicory, 15 parts of chrysanthemum, 9 parts of perilla leaves, 5 parts of perilla stems, 6 parts of fructus amomi, 10 parts of lettuce seeds, 30 parts of fried white hyacinth beans and 10 parts of liquorice.
Example 8 Pu Shu tea composition (eight)
The raw material medicaments are taken according to the following weight portion:
15 parts of dandelion, 25 parts of rose, 10 parts of chicory, 30 parts of chrysanthemum, 3 parts of perilla leaves, 12 parts of perilla stems, 3 parts of fructus amomi, 20 parts of lettuce seeds, 15 parts of fried white hyacinth beans and 12 parts of liquorice.
Example 9 Pu Shu tea composition (nine)
The raw material medicaments are taken according to the following weight portion:
25 parts of dandelion, 15 parts of rose, 20 parts of chicory, 15 parts of chrysanthemum, 12 parts of perilla leaves, 3 parts of perilla stems, 6 parts of fructus amomi, 10 parts of lettuce seeds, 25 parts of fried white hyacinth beans and 7 parts of liquorice.
Example 10 Pu Shu tea composition (Ten)
The raw material medicaments are taken according to the following weight portion:
20 parts of dandelion, 20 parts of rose, 20 parts of chicory, 20 parts of chrysanthemum, 9 parts of perilla leaves, 9 parts of perilla stems, 5 parts of fructus amomi, 20 parts of lettuce seeds, 20 parts of fried white hyacinth beans and 10 parts of liquorice.
Example 11 Pu Shu tea composition (eleven)
The raw material medicaments are taken according to the following weight portion:
27 parts of dandelion, 20 parts of rose, 20 parts of chicory, 20 parts of chrysanthemum, 9 parts of perilla leaves, 9 parts of perilla stems, 5 parts of fructus amomi, 20 parts of lettuce seeds, 20 parts of fried white hyacinth beans and 10 parts of liquorice.
Example 12 Pu Shu tea composition (twelve)
The raw material medicaments are taken according to the following weight portion:
28 parts of dandelion, 20 parts of rose, 20 parts of chicory, 20 parts of chrysanthemum, 9 parts of perilla leaves, 9 parts of perilla stems, 5 parts of fructus amomi, 20 parts of lettuce seeds, 20 parts of fried white hyacinth beans and 10 parts of liquorice.
Example 13 Pu Shu tea composition (thirteen)
The raw material medicaments are taken according to the following weight portion:
26 parts of dandelion, 20 parts of rose, 20 parts of chicory, 20 parts of chrysanthemum, 9 parts of perilla leaves, 9 parts of perilla stems, 5 parts of fructus amomi, 20 parts of lettuce seeds, 20 parts of fried white hyacinth beans and 10 parts of liquorice.
Example 14 Pu Shu tea composition (fourteen)
The raw material medicaments are taken according to the following weight portion:
29 parts of dandelion, 20 parts of rose, 20 parts of chicory, 20 parts of chrysanthemum, 9 parts of perilla leaves, 9 parts of perilla stems, 5 parts of fructus amomi, 20 parts of lettuce seeds, 20 parts of fried white hyacinth beans and 10 parts of liquorice.
Example 15 preparation of the invention
The preparation method comprises the following steps: after 500ml of water is boiled, the hydrophobic tea composition of any one of the cattail in the examples 1-14 is added, and the mixture is decocted for 20 minutes with small fire and is drunk as tea.
EXAMPLE 16 evaluation of Effect (I)
First, clinical observation
1. Clinical data: 180 lactation patients (acute mastitis) are diagnosed from 2018, 1 month to 2018, 12 months, and the patients are 20-42 years old, and 31.2 years old on average. The group is divided into 30 cases in the first treatment group, 30 cases in the second treatment group, 30 cases in the third treatment group, 30 cases in the fourth treatment group, 30 cases in the first comparison group and 30 cases in the second comparison group according to the non-random synchronization control.
The six data groups are statistically checked in age, disease course and other aspects, have no obvious difference and are comparable among groups.
2. Diagnostic criteria: according to the diagnosis standard of acute mastitis in the 'traditional Chinese medicine disease diagnosis curative effect standard', the breast is caked, the local part is red, swollen and hot, and is accompanied or not accompanied with general symptoms such as fever and chilly.
3. The treatment method comprises the following steps:
treatment group one: the Pu Shu tea composition of the embodiment 1 is taken 1 patch a day, and decocted for 20 minutes with small fire to be drunk instead of tea. One course of treatment is given for 5 days, and two courses of treatment are observed.
Treatment group two: the Pu Shu tea composition of the embodiment 3 is taken 1 patch a day, decocted for 20 minutes with small fire and drunk as tea. One course of treatment is given for 5 days, and two courses of treatment are observed.
Treatment group three: the 10 Pu Shu tea composition of the embodiment is taken 1 plaster a day, decocted for 20 minutes with small fire and drunk as tea. One course of treatment is given for 5 days, and two courses of treatment are observed.
And C, treatment group four: the 13 Pu Shu tea composition of the embodiment is taken 1 plaster a day, decocted for 20 minutes with small fire and drunk as tea. One course of treatment is given for 5 days, and two courses of treatment are observed.
Control group one: the tea substitute drink (after 500ml of water is boiled, 20g of dandelion, 20g of radix curcumae, 20g of chicory, 20g of chrysanthemum, 9g of perilla leaf, 9g of codonopsis pilosula, 5g of fructus amomi, 20g of lettuce seeds, 20g of fried white hyacinth bean and 10g of liquorice are added, and the mixture is decocted for 20 minutes by small fire to be drunk as the tea substitute drink) is taken for 5 days for one treatment course, and two treatment courses are observed.
Control group two: taking the tea substitute drink (after 500ml of water is boiled, 20g of dandelion, 20g of rose, 20g of chicory, 20g of chrysanthemum, 16g of perilla leaf, 18g of caulis perllae, 5g of fructus amomi, 33g of lettuce seeds, 20g of fried white hyacinth bean and 4g of liquorice, decocting for 20 minutes with slow fire, and drinking the tea substitute drink) for 5 days as a treatment course, and observing two treatment courses.
4. The evaluation standard of curative effect is as follows: curing, namely eliminating the symptoms of the whole body, dissipating the lumps and healing the sore; the effect is shown: the symptoms of the whole body disappear, the mass is obviously reduced, and the opening of the sore is reduced; the method has the following advantages: the general symptoms disappear, the local swelling and pain is relieved, or the sore is not healed; no effect, no obvious change before and after treatment or serious reversal.
5. The treatment results are as follows: six groups of comparison have significant difference (P < 0.05), and the results are shown in Table 1.
TABLE 1 comparison of the efficacy of six groups of patients after two treatment courses
Figure BDA0002293667660000051
Figure BDA0002293667660000061
In the table, the four groups of treatment groups in the above table total 120, the total cure rate is 90, the effective rate is 10, the effective rate is 12, the ineffective rate is 8, and the total effective rate is 93.33%. And in 60 people in total in the two control groups, the total recovery rate is 20, the obvious effect rate is 8, the effective rate is 13, the ineffective rate is 19, and the total effective rate is 68.33%. Therefore, the total effective rate of 93.33 of the invention for treating patients is obviously higher than 68.33 percent of that of the control group, and the invention has obvious curative effect on acute mastitis and no toxic or side effect.
II, typical cases:
(1) plum mother, head and fetus, natural labor, 3 rd day after delivery, the breasts on both sides are expanded like stones, can not be touched, and the baby can not suck. After the traditional Chinese medicine is taken for 2 days, the breast distending pain is obviously relieved. Compared with other mothers with the same swelling degree in the same period, the degree of breast pain is obviously reduced, and the normal rest is basically not influenced.
(2) On day 2 of Zhangmama, second fetus, normal delivery and postpartum, the breast is observed to have a slight hyperemia sign, the hyperemia is expected to be fast, and the breast enters a physiological mammary swelling period.
(3) The fan mother, the head and the fetus, the birth following, the 8 days after delivery and the large nipple, because the baby does not suck the breast after illness, the two breasts of the mother are expanded like stones, the skin color is reddish, the pain cannot be felt, the breast can not be touched at all, the breast is not obviously improved during massage, the breast is gradually softened after the baby sucks the medicated wine for three days, and the breast does not pain and swell after 3 days.
(4) The golden mother, caesarean delivery, 9 days postpartum, the whole swelling of the right breast as a pan, slightly better left side, no bean-like feeling, bright red whole breast, fast breast filling speed, but no milk production. Before it there was a history of breast massage in months. After the breast swelling degree of the breast is obviously improved after the breast is taken for one day, the breast swelling degree can be completely sprayed after the breast is continuously taken for the next day by matching with dredging and massaging, and except local breast swelling (with edema and needing time to be absorbed by a body), other breast parts are soft.
(5) Aged mother, head fetus, normal birth, 3 months after delivery, and the breast has local stasis and bean-like feeling. After the present invention is taken for 1 day, the local mass of the breast becomes smaller and softer, and the next day, the mass disappears after the breast is sucked by a baby.
(6) Yumama, two fetuses, caesarean delivery, 20 days after delivery, big and soft breasts with big eggs and little milk, the milk can be sprayed after the breasts are dredged by the manipulation, big lumps basically disappear, a little bean-like small lumps remain, and the baby feeding cup can suck more and has no lumps in the next day.
(7) The mamma, the head and the fetus, the cesarean section, 4 months after delivery, the left breast has about 1/2 mass of the breast, the mass is hard and red, the small white spots on the breast are observed, the small white spots are picked up, and the nose tip of the baby sucks the mass for five minutes and completely disappears. The thick milk of the mother is the reason of the occurrence of small white spots, and the baby can feed back the thick milk and the sucking is not laboursome when the baby drinks the milk for 3 days.
(8) The formula is used for treating the symptoms of the old mother, the head fetus, the natural labor, 2 months after delivery, small bean-like agglomeration on both sides of the breast, distending pain, more milk, quick milk secretion, obvious bean-like feeling during milk secretion, slight red color, slightly hot breast temperature, reduction after dredging of the breast by a manipulation, normal breast temperature, increased sucking frequency of a baby with orders, frequent drinking for three days after adding the formula and relief after 2 days.
(9) The pregnant woman is born with a head fetus, is in normal delivery, is 40 days after delivery, has the upper half part of the breast agglomerated with edema, has bean-like sensation of agglomeration, has red breast, is hot, has the body temperature of 38.5, and has the symptoms of immobility and dysphoria of babies, obvious general symptoms of the pregnant woman, and has a cold body and similar symptoms of cold. The breast lumps are reduced after the manipulation is carried out for dredging, but edema lumps still exist, the body temperature is unchanged, the whole body symptoms are not obviously improved, the baby can suck the breast and take the breast-dredging decoction, the whole body symptoms are obviously relieved on day 2, the body temperature is still 38.5, the baby takes the breast-dredging decoction again and then takes the breast-dredging decoction to continue the breast-dredging decoction, the sucking frequency of the baby is increased, and the breast-dredging decoction is burnt off at night on the same day.
(10) High mom, first fetus, normal birth, 8 months after delivery, weaning 3 days, because of sudden weaning breast distending pain and severe fever, redness, body temperature 37.8. The invention is matched with the milk for one week, the breast distending pain is obviously relieved, and the milk is smoothly returned.
(11) Mother in mother, first fetus, 6 months after delivery. The breast had very small three lumps with bean-like sensation, and the breast had a slightly higher temperature and red lumps with no heat generation at present for two days before the fever. After the medicine is taken for 3 days, the mammary gland is unobstructed, and the breast can be smoothly fed to the age of more than 2 years old.
(12) Zhao mother, head fetus, direct labor, 10 days after delivery, the upper part of the outer side of the left breast is provided with lumps with edema, red and red, the red and swollen part is scalded, the periphery of the breast becomes soft after dredging, the breast lumps become small, a little bit of skin temperature comes, the invention is frequently drunk by a user one day, and the skin temperature is basically normal on the next day. The breast mass disappeared after three days. Then nursing normally for more than 8 months.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, various modifications and additions can be made without departing from the principle of the present invention, and these should also be considered as the protection scope of the present invention.

Claims (5)

1. The Pu Shu tea is characterized by being prepared from the following raw material medicines in parts by weight: 10-30 parts of dandelion, 10-30 parts of rose, 10-30 parts of chicory, 10-30 parts of chrysanthemum, 3-15 parts of perilla leaves, 3-15 parts of caulis perillae, 3-6 parts of fructus amomi, 10-30 parts of lettuce seeds, 10-30 parts of fried white hyacinth beans and 5-15 parts of liquorice.
2. The Pu Shu tea as claimed in claim 1, which is prepared from the following raw material medicines in parts by weight: 15-25 parts of dandelion, 15-25 parts of rose, 15-25 parts of chicory, 15-25 parts of chrysanthemum, 5-12 parts of perilla leaves, 5-12 parts of caulis perllae, 3-6 parts of fructus amomi, 15-25 parts of lettuce seeds, 15-25 parts of fried white hyacinth beans and 7-12 parts of liquorice.
3. The Pu Shu tea as claimed in claim 1, which is prepared from the following raw material medicines in parts by weight: 20 parts of dandelion, 20 parts of rose, 20 parts of chicory, 20 parts of chrysanthemum, 9 parts of perilla leaves, 9 parts of perilla stems, 5 parts of fructus amomi, 20 parts of lettuce seeds, 20 parts of fried white hyacinth beans and 10 parts of liquorice.
4. Use of the Pu Shu tea according to any of claims 1-3 for the preparation of a medicament for the treatment of acute mastitis.
5. The use of claim 4, wherein said acute mastitis condition is: breast distending pain, milk stasis, thick milk, early mastitis, and early stage pus formation in lactation.
CN201911191416.5A 2019-11-28 2019-11-28 Pu Shu tea and application thereof Active CN110755571B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911191416.5A CN110755571B (en) 2019-11-28 2019-11-28 Pu Shu tea and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911191416.5A CN110755571B (en) 2019-11-28 2019-11-28 Pu Shu tea and application thereof

Publications (2)

Publication Number Publication Date
CN110755571A CN110755571A (en) 2020-02-07
CN110755571B true CN110755571B (en) 2021-11-30

Family

ID=69339839

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911191416.5A Active CN110755571B (en) 2019-11-28 2019-11-28 Pu Shu tea and application thereof

Country Status (1)

Country Link
CN (1) CN110755571B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1915290A (en) * 2006-08-25 2007-02-21 黄志良 Medication of medical broth for treating acute mastitis, and preparation method
CN105232916A (en) * 2015-10-14 2016-01-13 王晓燕 Herba-taraxaci traditional Chinese medicine wine
CN108478631A (en) * 2018-05-21 2018-09-04 南通峰巢工业设计有限公司 A kind of formula for controlling hypermastia
CN108651652A (en) * 2017-03-29 2018-10-16 哈尔滨市兴隆林业局药材公司 Witloof compound surrogated tea
CN108743850A (en) * 2018-07-04 2018-11-06 蔡国英 A kind of Chinese medicine preparation for nursing period acute mastitis

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1915290A (en) * 2006-08-25 2007-02-21 黄志良 Medication of medical broth for treating acute mastitis, and preparation method
CN105232916A (en) * 2015-10-14 2016-01-13 王晓燕 Herba-taraxaci traditional Chinese medicine wine
CN108651652A (en) * 2017-03-29 2018-10-16 哈尔滨市兴隆林业局药材公司 Witloof compound surrogated tea
CN108478631A (en) * 2018-05-21 2018-09-04 南通峰巢工业设计有限公司 A kind of formula for controlling hypermastia
CN108743850A (en) * 2018-07-04 2018-11-06 蔡国英 A kind of Chinese medicine preparation for nursing period acute mastitis

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
三赤二甘汤治疗哺乳期急性乳腺炎;尚春香;《山西中医》;20010228(第01期);第2页下半部分左栏 *
中医药治疗急性乳腺炎早期的临床观察;熊娟;《湖北中医杂志》;20091210(第12期);第51页 *
中药蒲公英合剂治疗急性乳腺炎有效;安徽军区后勤直属门诊部;《人民军医》;19611231(第7期);第24页 *
单味蒲公英煎剂治疗产后急性乳腺炎25例;林洁等;《实用医药杂志》;20070831;第24卷(第8期);第943页 *
治急性乳腺炎方;徐延良等;《湖南中医杂志》;19931231(第04期);第10页 *
蒲公英临证应用探析;黎俊民;《四川中医》;20040915(第09期);第32页 *

Also Published As

Publication number Publication date
CN110755571A (en) 2020-02-07

Similar Documents

Publication Publication Date Title
CN102188614A (en) Capsule for gastric ulcer
CN103705863A (en) Traditional Chinese medicine for improving postoperative qi-yin deficiency of thyroid cancer
CN110755571B (en) Pu Shu tea and application thereof
CN114869949B (en) A pharmaceutical composition for treating puerperal diseases, and its preparation method
CN103356802B (en) Medicament for treating mastitis, and preparation method thereof
CN111450201B (en) Composition for improving acute mastitis and/or regulating breast function of puerpera
CN105288025B (en) A kind of Chinese medicine powder and preparation method thereof for treating liver qi stagnation type irregular menstruation
CN110742990B (en) Traditional Chinese medicine composition for treating non-alcoholic simple fatty liver, preparation and application
CN104524358B (en) A kind of pill and preparation method of auxiliary treatment hypoferric anemia
CN105434739A (en) Traditional Chinese medicine composition for treating chalazia and preparation method thereof
CN105126008A (en) Traditional Chinese medicine combination for treating infantile diarrhea and preparation method thereof
CN105287921A (en) Medicinal composition for treating gastric cancer and preparation method thereof
CN110464818A (en) A kind of Chinese medicine composition for treating cervical carcinoma
CN104623152A (en) Traditional Chinese medicine composition for treating thyroid adenoma due to phlegm-damp stagnation and preparation method thereof
CN104644997A (en) Medicine for treating lobular hyperplasia of mammary glands
CN104524312B (en) A kind of Chinese medicine composition and preparation method for the treatment of expectorant knot blood stasis type thyroid adenoma
CN107823533A (en) A kind of medicine for treating chronic ulcerative colitis
CN103223046A (en) Traditional Chinese medicine for treating hyperplasia of mammary glands
CN115645478B (en) Traditional Chinese medicine composition for treating primary dysmenorrhea and preparation method thereof
CN104474381B (en) A kind of Chinese medicine composition of delaactation and its application
CN115957264A (en) Traditional Chinese medicine composition for postpartum lactogenesis and preparation method thereof
CN112494579A (en) Anticancer traditional Chinese medicine formula for increasing leucocytes and improving immunity, decocting method and eating method
CN114748576A (en) Medicinal and edible twenty-flavor radix pseudostellariae and sea buckthorn paste and preparation method thereof
CN112451634A (en) Formula for treating duodenal gastritis and erosive gastritis
CN103800724A (en) Traditional Chinese medicine for treating thyroiditis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant